Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    23531349 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: FTY720;   Drug: Placebo
2 Completed
Has Results
Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis
Condition: Relapsing-remitting Multiple Sclerosis
Interventions: Drug: Fingolimod 1.25 mg;   Drug: Fingolimod 0.5 mg;   Drug: Placebo
3 Completed
Has Results
Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod 1.25 mg;   Drug: Fingolimod 0.5 mg;   Drug: Interferon β-1a 30 µg

Indicates status has not been verified in more than two years